Table 1. List of All Racemic NMEs Approved by The FDA from 2013 to 2022.

year approved	medicine name	active substance	therapeutic area	indication/use	no. stereocenters
2013	Pomalyst	pomalidomide	cancer	multiple myeloma	1
2015	Zurampic	lesinurad	rheumatology	gout	0a
2015	Farydak	panobinostat lactate	cancer	multiple myeloma	1b
2015	Cresemba	isavuconazonium sulfate	infections	aspergillosis	3c
2018	Diacomit	stiripentol	neurology	anticonvulsant	1
2018	Krintafel	tafenoquine	infection	malaria	1
2020	Barhemsys	amisulpride	gastroenterology	nausea and vomiting	1
2020	Lampit	nifurtimox	infection	Chagas disease	1
2021	Qelbree	viloxazine	psychiatry	ADHD	1
2022	Elucirem	gadopiclenol	diagnostic imaging	detection and visualization of lesions	6d

^aLesinurad displays axial chirality.

^bThe stereocenter is located on the lactate counterion.

^cOne of the three stereocenters of isavuconazonium sulfate is undefined. It is marketed as a mixture of epimers.

^dThe stereochemistry of all six stereocenters of gadopiclenol is undefined. It is marketed as a mixture of diastereomers.